← Back to Search

Option Grid Decision Aid for Prostate Cancer

N/A
Waitlist Available
Led By Mary Politi, Ph.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month follow-up
Awards & highlights

Study Summary

This trial will show if giving patients cost information about their treatment options, as well as training doctors to discuss costs, reduces financial stress for patients with slow-growing prostate cancer while also maintaining high-quality decision-making.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Frequency of cost conversations
Initiator (surgeon, patient, or caregiver) of cost conversations
Whether or not a referral is made to address costs
Secondary outcome measures
Intersectoral Collaboration
Other outcome measures
Decision regret
Financial toxicity
Number of patients who had a decisional conflict

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 2: Option GridExperimental Treatment1 Intervention
Each participating urologic surgeon will begin in the usual care arm of the study. Subsequently, they will be randomized to the intervention arm at staggered time points to undergo training and begin using the Option Grid decision aid intervention with patients who are diagnosed with slow-growing prostate cancer. Decision Aid-Participating surgeons use an encounter decision aid to discuss treatment options with patients who have slow-growing prostate cancer. Visits are audio-recorded and/or evaluated by patient self-report measure.
Group II: Arm 1: Usual CareActive Control1 Intervention
Each participating urologic surgeon will begin in the usual care arm of the study. Subsequently, they will be randomized to the intervention arm at staggered time points to undergo training and begin using the Option Grid decision aid intervention with patients who are diagnosed with slow-growing prostate cancer. Usual Care-Participating clinicians have treatment options discussion with patients with slow-growing prostate cancer. Visits are audio-recorded and/or described by patient self-report measure.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Option Grid Decision Aid
2020
N/A
~120

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,936 Previous Clinical Trials
2,299,573 Total Patients Enrolled
17 Trials studying Prostate Cancer
4,154 Patients Enrolled for Prostate Cancer
Robert Wood Johnson FoundationOTHER
157 Previous Clinical Trials
686,717 Total Patients Enrolled
Mary Politi, Ph.D.Principal InvestigatorWashington University School of Medicine
2 Previous Clinical Trials
562 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Cost Talk: Discussing Cancer Care Costs
2020. "Cost Talk: Discussing Cancer Care Costs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04397016.
~24 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top